Tang Chih-Hsin, Yang Rong-Sen, Fu Wen-Mei
Departments of Pharmacology and Orthopaedics, College of Medicine, National Taiwan University, Taipei, Taiwan.
J Biol Chem. 2005 Jun 17;280(24):22907-16. doi: 10.1074/jbc.M500130200. Epub 2005 Apr 15.
Fibronectin (Fn) is involved in the early stages of bone formation, and prostaglandin E (PGE) is an important factor regulating osteogenesis. Here we found that PGE(2) enhanced extracellular Fn assembly in rat primary osteoblasts, as shown by immunofluorescence staining and enzyme-linked immunosorbent assay. PGE(2) also increased the protein levels of Fn by using Western blotting analysis. By using pharmacological inhibitors or activators or genetic inhibition by the EP receptor, antisense oligonucleotides revealed that the EP(1) receptor but not other PGE receptors is involved in PGE(2)-mediated up-regulation of Fn. At the mechanistic level, Ca(2+) chelator (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetrakis(acetoxymethyl ester)), phosphatidylinositol-phospholipase C inhibitor (U73122), or Src inhibitor (PP2) attenuated the PGE(2)-induced Fn expression. Protein kinase C (PKC) inhibitor (GF109203X) also inhibited the potentiating action of PGE(2). Furthermore, treatment with antisense oligonucleotides of various PKC isoforms, including alpha, beta, epsilon, and delta, demonstrated that alpha isozyme plays an important role in the enhancement action of PGE(2) on Fn assembly. Flow cytometry and reverse transcription-PCR showed that PGE(2) and 17-phenyl trinor PGE(2) (EP(1)/EP(3) agonist) increased the surface expression and mRNA level of alpha5 or beta1 integrins. Fn promoter activity was enhanced by PGE(2) and 17-phenyl trinor PGE(2) in cells transfected with pGL2F1900-Luc. Cotransfection with dominant negative mutants of PKCalpha or c-Src inhibited the potentiating action of PGE(2) on Fn promoter activity. Local administration of PGE(2) or 17-phenyl trinor PGE(2) into the metaphysis of the tibia via the implantation of a needle cannula significantly increased the Fn and alpha5beta1 integrin immunostaining and bone volume of secondary spongiosa in tibia. Taken together, our results provided evidence that PGE(2) increased Fn and promoted bone formation in rat osteoblasts via the EP(1)/phospholipase C/PKCalpha/c-Src signaling pathway.
纤连蛋白(Fn)参与骨形成的早期阶段,而前列腺素E(PGE)是调节成骨的重要因素。在此我们发现,如免疫荧光染色和酶联免疫吸附测定所示,PGE₂增强了大鼠原代成骨细胞中细胞外Fn的组装。通过蛋白质印迹分析,PGE₂还增加了Fn的蛋白水平。使用药理学抑制剂或激活剂或通过EP受体进行基因抑制,反义寡核苷酸显示EP₁受体而非其他PGE受体参与PGE₂介导的Fn上调。在机制层面,Ca²⁺螯合剂(1,2-双(2-氨基苯氧基)乙烷-N,N,N',N'-四乙酸四钾盐(乙酰氧甲酯))、磷脂酰肌醇-磷脂酶C抑制剂(U73122)或Src抑制剂(PP2)减弱了PGE₂诱导的Fn表达。蛋白激酶C(PKC)抑制剂(GF109203X)也抑制了PGE₂的增强作用。此外,用包括α、β、ε和δ在内的各种PKC同工型的反义寡核苷酸处理表明,α同工酶在PGE₂对Fn组装的增强作用中起重要作用。流式细胞术和逆转录-PCR显示,PGE₂和17-苯基三降PGE₂(EP₁/EP₃激动剂)增加了α5或β1整合素的表面表达和mRNA水平。在转染了pGL2F1900-Luc的细胞中,PGE₂和17-苯基三降PGE₂增强了Fn启动子活性。与PKCα或c-Src的显性负性突变体共转染抑制了PGE₂对Fn启动子活性的增强作用。通过针套管植入将PGE₂或17-苯基三降PGE₂局部注射到胫骨干骺端,显著增加了胫骨次级海绵体中Fn和α5β1整合素的免疫染色以及骨体积。综上所述,我们的结果证明PGE₂通过EP₁/磷脂酶C/PKCα/c-Src信号通路增加Fn并促进大鼠成骨细胞的骨形成。